Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Regulated Stimulation for Optimized Network Activity and Therapeutic Equilibrium

NCT: NCT07594483 · RECRUITING

NCT IDNCT07594483
StatusRECRUITING
SponsorMotif Neurotech, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

The objective of this study is to evaluate the safety, tolerability, and preliminary efficacy of the Motif eXternally powered Cortical Stimulation (XCS) System when used as indicated for treatment-resistant depression (TRD).

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑